https://www.selleckchem.com/pr....oducts/fasoracetam-n
Although the role of obesity-induced metabolic abnormalities in impaired lung function is well-established, the risk of impaired lung function among obese individuals without metabolic abnormalities, referred to metabolically-healthy obesity (MHO), is largely unexplored. Therefore, we evaluated the impact of MHO on lung function in a large health-screening cohort. 114,143 subjects (65,342 men, mean age and BMI 39.6 years and 23.6) with health examinations in 2019 were divided into four groups as follows metabolically healthy
Like
Comment
Share
